Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model

Pulmonary arterial hypertension (PAH) is characterised by sustained pulmonary vasoconstriction and remodelling of the pulmonary circulation leading to progressive right ventricular (RV) dysfunction. Although recent registry data suggest improving outcomes, PAH still carries a high morbidity and mortality burden [1].

Source: European Respiratory Journal - October 18, 2018 Category: Respiratory Medicine Authors: Mercurio, V., Diab, N., Peloquin, G., Housten-Harris, T., Damico, R., Kolb, T. M., Mathai, S. C., Hassoun, P. M. Tags: Original Articles: Research letters Source Type: research